Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
It is my belief and understanding that PTSC had previously implemented a semi annual dividend policy. If licensing activity begins to pick up now that there has been a settlement between TPL and PTSC, do you think they should pay shareholders a dividend?
I guess if we suddenly see Cliff, Gloria and Carl acquiring shares, it might be more of a sure thing that dividends will be forthcoming.
